Holen Sie sich die Stockscreener-App
0.6649
0.33%
0.0022
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Immunic targets MS market with Phase 3 dataICYMI - Proactive financial news
Can Immunic Inc. stock beat market expectations this quarterTrade Entry Report & AI Driven Stock Price Forecasts - ulpravda.ru
Earnings Update: Will Immunic Inc stock see insider buyingJuly 2025 Drop Watch & Consistent Income Trade Recommendations - moha.gov.vn
Can Immunic Inc. stock maintain operating marginsJobs Report & Consistent Profit Trade Alerts - ulpravda.ru
Will Immunic Inc. stock see insider buyingJuly 2025 Volume & High Accuracy Investment Entry Signals - ulpravda.ru
Why Immunic Inc. (10VA) stock appears on watchlists2025 Buyback Activity & Long-Term Growth Portfolio Plans - ulpravda.ru
Will Immunic Inc. stock keep outperforming rivals2025 Growth vs Value & Reliable Entry Point Alerts - ulpravda.ru
Immunic (NASDAQ:IMUX) Given Buy Rating at D. Boral Capital - Defense World
Immunic looks to 2026 data as late-stage MS program advances - Proactive financial news
Immunic CEO on key 2025 highlights and 2026 milestones - Proactive financial news
EQS-News: Immunic AG: Immunic Highlights 2025 Accomplishments and Upcoming Milestones - FinanzNachrichten.de
Immunic Highlights 2025 Accomplishments and Upcoming Milestones - PR Newswire
Immunic Transfers Listing to Nasdaq Capital Market for Compliance - TipRanks
Immunic to transfer listing to Nasdaq Capital Market after bid price non-compliance - Investing.com
Immunic Announced Transfer or Voluntary Withdrawal of Listing - TradingView — Track All Markets
Immunic (NASDAQ:IMUX) Shares Up 9.3% – Should You Buy? - Defense World
Immunic appoints Duane Nash as CEO of new subsidiary Gliomic, updates executive agreements - Investing.com Australia
Immunic appoints Duane Nash as CEO of new subsidiary Gliomic, updates executive agreements By Investing.com - Investing.com South Africa
Immunic, Inc. Announces Executive Role Changes - TradingView — Track All Markets
Immunic (IMUX) Has a New Rating from Chardan Capital - The Globe and Mail
Celiac Disease Market Report 2025-2035: Drivers, Challenges, Opportunities, Industry Trends and Case Studies - GlobeNewswire Inc.
Immunic Earnings Notes - Trefis
Gainers Report: Will Immunic Inc 10VA stock benefit from mergers2025 Fundamental Recap & Reliable Breakout Forecasts - moha.gov.vn
Will Immunic Inc. (10VA) stock benefit from mergersJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Will Immunic Inc. (10VA) stock extend growth storyWeekly Trade Summary & AI Based Buy/Sell Signal Reports - DonanımHaber
Why Immunic Inc. (10VA) stock stays resilientQuarterly Profit Review & Daily Chart Pattern Signals - DonanımHaber
Will Immunic Inc. stock outperform international peersStock Surge & Intraday High Probability Alerts - Улправда
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and Immunic (IMUX) - The Globe and Mail
Immunic Inc (IMUX)’s stock performance: a year in review - uspostnews.com
Immunic launches public offering of warrants to fund clinical trials; shares down - MSN
683 Capital Management LLC Reduces Stake in Immunic, Inc. $IMUX - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Analysts - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts - MarketBeat
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Immunic Inc - GuruFocus
How does Immunic Inc (IMUX) change from a tortoise to a hare? - setenews.com
Immunic’s long-term treatment hope for multiple sclerosis – ICYMI - Proactive financial news
Operating income of Immunic, Inc. – HAM:10VA - TradingView
Will Immunic Inc. stock deliver better than expected guidanceRisk Management & Real-Time Buy Signal Alerts - Newser
How risky is Immunic Inc. stock nowJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Immunic Inc. (10VA) stock return to pre crash levels2025 Fundamental Recap & Consistent Profit Alerts - Newser
How supply chain issues affect Immunic Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Why Immunic Inc. (10VA) stock is a strong analyst pickPortfolio Gains Summary & Technical Pattern Alert System - Newser
Can Immunic Inc. (10VA) stock withstand sector downturnsTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Is Immunic Inc. stock near bottom after declineOil Prices & Daily Momentum Trading Reports - Newser
How Immunic Inc. stock performs in stagflation2025 Investor Takeaways & Target Return Focused Picks - Newser
Immunic marks International Day of Persons with Disabilities with hope for MS sufferers - Proactive financial news
What consensus target says about Immunic Inc. (10VA) stockWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Immunic Inc. stock is considered a top pickPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Will Immunic Inc. (10VA) stock outperform Dow JonesTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
IMUX stock touches 52-week low at $0.92 amid market challenges - MSN
Will Immunic Inc. (10VA) stock outperform global peers2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):